VCEL FY 2014 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M+151457.9% YoY

Gross Profit

$12M39.9% margin

Operating Income

-$24M-81.7% margin

Net Income

-$20M-69.2% margin

EPS (Diluted)

$-1.71

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$839,000

Balance Sheet

Total Assets

$48M

Total Liabilities

$12M

Stockholders' Equity

$36M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$19,000	+151457.9%
Gross Profit	$12M	$15,000	+76586.7%
Operating Income	-$24M	-$21M	-12.3%
Net Income	-$20M	-$16M	-27.5%